Literature DB >> 23085942

Physiologic response to a simplified venovenous perfusion-induced systemic hyperthermia system.

Cherry Ballard-Croft1, Dongfang Wang, Cameron Jones, L Ryan Sumpter, Xiaoqin Zhou, Joe Thomas, Stephen Topaz, Joseph B Zwischenberger.   

Abstract

Our original venovenous perfusion-induced systemic hyperthermia (vv-PISH) system appeared to significantly improve the survival of patients with lung cancer, but was too complex with numerous dialysis problems. We tested a simplified vv-PISH circuit that includes the Avalon Elite (Avalon Laboratories, LLC, Rancho Dominguez, CA) double lumen cannula, a modified heat exchanger, a water heater/cooler, and a centrifugal pump. The purpose of this study was to evaluate this simplified vv-PISH system (without hemodialyzer) and to investigate the physiologic response to whole-body hyperthermia in pigs. We tested our vv-PISH circuit in healthy adult female swine (n = 7, 55-68 kg). The therapeutic core temperature (42°C), calculated as mean of rectal, bladder, and esophageal temperatures, was achieved in six swine. A maximum difference of 0.5°C was observed between the individual temperature sensor readings, indicating homogeneous heat distribution. Heart rate and mean arterial pressure were transiently altered, but were safely managed. A significant elevation in pulmonary artery pressure occurred during the heating phase, resulting in death of one pig. In all other pigs, pulmonary artery pressure returned to physiologic values during the therapeutic phase. Arterial blood electrolytes were maintained without the need of a dialyzer. Major organ function was within normal parameters. The simplified vv-PISH circuit reliably delivered the hyperthermic dose with no need of dialysis.

Entities:  

Mesh:

Year:  2012        PMID: 23085942      PMCID: PMC4407565          DOI: 10.1097/MAT.0b013e318271badb

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  17 in total

1.  Venovenous perfusion-induced systemic hyperthermia: hemodynamics, blood flow, and thermal gradients.

Authors:  R A Vertrees; A Bidani; D J Deyo; W Tao; J B Zwischenberger
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

Review 2.  Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field.

Authors:  Harm H Kampinga
Journal:  Int J Hyperthermia       Date:  2006-05       Impact factor: 3.914

3.  Wang-Zwische double lumen cannula-toward a percutaneous and ambulatory paracorporeal artificial lung.

Authors:  Dongfang Wang; Xiaoqin Zhou; Xiaojun Liu; Bill Sidor; James Lynch; Joseph B Zwischenberger
Journal:  ASAIO J       Date:  2008 Nov-Dec       Impact factor: 2.872

4.  Whole body hyperthermia: a secure procedure for patients with various malignancies?

Authors:  T Kerner; M Deja; O Ahlers; J Löffel; B Hildebrandt; P Wust; H Gerlach; H Riess
Journal:  Intensive Care Med       Date:  1999-09       Impact factor: 17.440

5.  Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer.

Authors:  Friedrich Douwes; Juri BogoviC; Ortrun Douwes; Friedrich Migeod; Christoph Grote
Journal:  Int J Clin Oncol       Date:  2004-04       Impact factor: 3.402

6.  Anaesthesiological experiences with whole body hyperthermia.

Authors:  T Kerner; B Hildebrandt; O Ahlers; M Deja; H Riess; J Draeger; P Wust; H Gerlach
Journal:  Int J Hyperthermia       Date:  2003 Jan-Feb       Impact factor: 3.914

7.  Monitoring of whole-body hyperthermia with transesophageal echocardiography (TEE).

Authors:  Antje Fippel; Alexandra Von Sandersleben; Katrin Bangert; Jeannette Horn; Axel Nierhaus; Frank Wappler
Journal:  Int J Hyperthermia       Date:  2007-08       Impact factor: 3.914

Review 8.  Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application.

Authors:  J W J Bergs; N A P Franken; J Haveman; E D Geijsen; J Crezee; C van Bree
Journal:  Int J Hyperthermia       Date:  2007-06       Impact factor: 3.914

Review 9.  Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea.

Authors:  Jesus Esquivel
Journal:  Cancer J       Date:  2009 May-Jun       Impact factor: 3.360

10.  Docetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study.

Authors:  Zhu Jiang; Wang Yan; Jiang Ming; Yang Yu
Journal:  BMC Cancer       Date:  2007-10-06       Impact factor: 4.430

View more
  4 in total

1.  Venovenous perfusion-induced systemic hyperthermia: five-day sheep survival studies.

Authors:  Cherry Ballard-Croft; Dongfang Wang; Kyle Rosenstein; Jingkun Wang; Robert Pollock; J Ann Morris; Joseph B Zwischenberger
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-05       Impact factor: 5.209

2.  Resolution of pulmonary hypertension complication during venovenous perfusion-induced systemic hyperthermia application.

Authors:  Cherry Ballard-Croft; Dongfang Wang; Cameron Jones; Jingkun Wang; Robert Pollock; Bob Jubak; Stephen Topaz; Joseph B Zwischenberger
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

Review 3.  Chinese Herbal Medicine for Functional Abdominal Pain Syndrome: From Clinical Findings to Basic Understandings.

Authors:  Tao Liu; Ning Wang; Li Zhang; Linda Zhong
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629

4.  Thermal distribution, physiological effects and toxicities of extracorporeally induced whole-body hyperthermia in a pig model.

Authors:  Gerben Lassche; Tim Frenzel; Marcel H Mignot; Marianne A Jonker; Johannes G van der Hoeven; Carla M L van Herpen; Gert Jan Scheffer
Journal:  Physiol Rep       Date:  2020-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.